Call us: 1.405.235.2305
info@i2E.org
  • Events
  • News
  • Resources
  • Library
  • Love’s Cup
i2Ei2Ei2Ei2E
  • About
  • Entrepreneurship
    • Venture Advisory Services
    • Love’s Entrepreneur’s Cup
  • e3
  • Concept Fund
  • iMCI
  • Portfolio
  • Contact

Business of Health: Major deals, Innovation District top local health stories for 2016

    Home News Business of Health: Major deals, Innovation District top local health stories for 2016
    NextPrevious

    Business of Health: Major deals, Innovation District top local health stories for 2016

    By sarah | News | 0 comment | 2 January, 2017 | 0

    By Stephen Prescott, M.D.
    Copyright © 2017, The Oklahoma Publishing Co.

    Happy New Year!

    In the world of health and business, 2016 brought its share of headlines. But many of those stories read like the ghosts of Christmases past.

    There was outrage over a massive price hike for an old drug (EpiPen). Health insurance costs (most notably the plans offered through Obamacare) skyrocketed. And a major American drugmaker (Pfizer) nearly moved its headquarters overseas as a tax dodge.

    Locally, though, the leading stories were fresh and new. Plus, in contrast to their national counterparts, these developments were decidedly upbeat, heralding exciting things to come in 2017 and beyond in Oklahoma City.

    Novartis acquires local biotech firm

    Dr. Rod McEver is a long-time member of OMRF’s scientific staff, and he’s led their cardiovascular biology research program for a decade. McEver was recently named OMRF’s new vice president of research. He is photographed in a research laboratory at OMRF offices on NE 13 Street on Monday, Dec. 19, 2016. [Photo by Jim Beckel, The Oklahoman]

    When the world’s second largest drug company purchased Selexys Pharmaceuticals in November in a deal that could ultimately reach $665 million, it was the first many had heard of this Oklahoma City biotech company. But it’s a success story that’s been three decades in the making.

    In the 1980s, Dr. Rod McEver led a team of researchers at the University of Oklahoma Health Sciences Center that made a series of findings about a protein known as P-selectin. The protein, they found, plays an important role in allowing white blood cells to stick at the sites of injury or infection to promote healing. But in certain people, it can also cause excessive accumulation of the cells, leading to tissue injury and even organ damage.

    In 2002, with Dr. Richard Cummings, McEver co-founded Selexys around that research. They ran the company for a half-dozen years until 2008, when the pair recruited Dr. Scott Rollins as CEO. Rollins, an Oklahoma native who’d done graduate work at the Oklahoma Medical Research Foundation, had played a key role in building Alexion Pharmaceuticals from a startup to a $20-billion-plus biotech powerhouse.

    Over the next eight years, Rollins raised capital, licensed important discoveries from OMRF — where McEver had moved his lab — and spearheaded the creation and testing of an experimental drug to treat sickle cell disease. Just before Selexys unveiled the results of an extremely promising clinical trial of the drug, Novartis acquired the company.

    The Selexys story is a huge win for Oklahoma City. Unlike most of the city’s previous biotech successes, this one had a slate of local investors, so the Novartis buyout will benefit numerous Oklahomans who backed Selexys. It’s also created a much-needed drug for a painful and life-threatening disease that affects almost 100,000 Americans. The icing on the cake is that McEver and Rollins have already spun off a new company, Tetherex, which is based in Oklahoma City and is using selectin-based technologies to develop treatments for illnesses like cancer and Crohn’s disease.

    OU Medicine joins forces with Saints

    After 18 years of partnership with Nashville-based HCA Corp., OU Medicine announced in October that it would be ending that agreement to team up with the parent company of St. Anthony Hospital.

    Under the deal, HCA will receive a reported $750 million for its ownership stake in the OU Medical Centers in OKC and Edmond. Then OU, SSM Health Care (St. Anthony’s holding company) and the University Hospitals Authority and Trust will form a new nonprofit that will oversee the operations of what will become the Oklahoma City area’s largest health care provider and employer.

    For the deal to go through, there remain a significant number of approvals: federal, the state’s Contingency Review Board and the Oklahoma Supreme Court. And integrating the practices of a Catholic health provider with OU Medicine will involve some adjustments.

    Still, assuming all i’s get dotted and t’s crossed, the integrated, yet-to-be-named system will consist of OU Medical Centers in Oklahoma City and Edmond, St. Anthony’s and The Bone and Joint Hospitals in Oklahoma City, a pair of physicians networks and numerous regional health care centers. In other words, it’s going to be a health care powerhouse in the greater Oklahoma City area.

    A new TIF for the Innovation District

    The past few years have brought considerable discussion about creating a new “Innovation District” around the Oklahoma Health Center area just east of downtown. But 2016 delivered something more concrete for this initiative.

    In December, the Oklahoma City Council voted to create the city’s 11th tax increment financing (TIF) district. The new district stretches east from Automobile Alley and encompasses OUHSC, OMRF and numerous other health-related entities. The district also includes the new GE Global Oil & Gas Research Center.

    The TIF is projected to generate $52 million in new tax revenues. Those funds will now be budgeted for a variety of projects aimed at economic development, educational enhancement and neighborhood redevelopment in the Innovation District.

    With almost 18,000 jobs and general revenues approaching $4 billion each year, this area is a sleeping giant in Oklahoma City. Add in this new funding and the talented folks across the city now devoting their talents to this effort, the prospects are now bright for tapping the copious resources — human and otherwise — in this district to create a vibrant innovation hub.

    What shape this initiative will take remains to be seen. (Put a deck on the freeway, anyone?) But now that we have some momentum and funding, I’m confident that the end product will be a live-work-eat-play area where entrepreneurship thrives.

    A physician and medical researcher, Prescott is president of the Oklahoma Medical Research Foundation and can be emailed at omrf-president@omrf.org.

    Read the article at newsok.com

     

     

     

     

     

    Innovation District, M.D., OU Medicine, Rodger McEver, Selexys Pharmaceuticals, SSM Healthcare, St. Anthony Hospital, Stephen Prescott

    Related Posts

    • Prescott: A homegrown biotech success story

      By sarah | 0 comment

      By Stephen Prescott, M.D. When Novartis announced earlier this month that the U.S. Food and Drug Administration had approved the company’s new drug to treat sickle cell anemia, the press release didn’t mention Oklahoma. ButRead more

    • Business of Health: Moving forward with OKC’s Innovation District

      By sarah | 0 comment

      By Stephen Prescott, M.D. Copyright (2018) The Oklahoma Publishing Co. Rome wasn’t built in a day. Nor will Oklahoma City’s Innovation District be. But the past month has seen some exciting progress as our communityRead more

    • Stephen Prescott, M.D.: This is what an innovation district looks like

      By sarah | 0 comment

      By Stephen Prescott, M.D. Copyright © 2017, The Oklahoma Publishing Co. Imaging. It’s the ability to create a visual representation of something we cannot simply view with the naked eye. In biomedical research, imaging technologiesRead more

    • Initiative gets underway in OKC to develop a ‘Nucleus’ hub

      By admin | 0 comment

      In October, the Brookings Institute announced Oklahoma City as one of two pilot cities that are part of a study into developing an Innovation District. It already has held informational meetings and tours to gather ideas on just what that might look like.

    • An Emerging Tech Center: Oklahoma City creating the “Power of Place”

      By admin | 0 comment

      Two decades after Oklahoma City embraced a groundbreaking initiative that remade the city through a series of pay-as-you-go projects, another initiative is emerging with implications for economic development. In October, the Brookings Institution announced that Oklahoma City is one of two pilot cities included in a study about developing an innovation district in an area of the city heavily focused on biotechnology research.

    Leave a Comment

    Cancel reply

    Your email address will not be published. Required fields are marked *

    NextPrevious
    i2E-300dpi-Trans-Light
    • Events
    • News
    • Resources
    • Library
    • Love’s Cup

    Oklahoma City Office

    840 Research Parkway, Suite 250
    OKC, OK 73104
    PHONE 405/235-2305
    Click HERE for printable map with directions.

    Tulsa Office

    618 E. Third Street, Suite 1
    Tulsa, OK 74120
    PHONE 918/582-5592
    Click HERE for printable map with directions.
    Copyright 2021 i2E, Inc. | All Rights Reserved
    • About i2E
    • Services
    • Investments
    • Development
      • Love’s Cup
        • Forms
        • High Growth
        • Small Business
        • Timeline
    • Portfolio 3
    • Contact
    i2E